Get started
Author

Timothy T. Gordon‐Walker

Observed names: T Gordon-Walker, T T Gordon-Walker, T. Gordon-Walker, T. T. Gordon-Walker, T. T. Gordon‐Walker, T.T. Gordon-Walker, TT Gordon-Walker, Timothy Gordon-Walker, Timothy T Gordon-Walker, Timothy T. Gordon-Walker
Observed institutions: NHS Lothian, Ninewells Hospital, Edinburgh Royal Infirmary, Forth Valley Royal Hospital, Centre for Inflammation Research, The Queen's Medical Research Institute, Medical Research Council, University of Edinburgh
ORCID: 0000-0001-5849-8866
Observed ORCID: 0000-0001-5849-8866
OpenAlex ID: A5069941258
Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis
2012 · Prakash Ramachandran, Antonella Pellicoro, et al. · Proceedings of the National Academy of Sciences · 1,043
PDF
Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells
2010 · Jörg Schrader, Timothy T. Gordon-Walker, et al. · Hepatology · 745
Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function
2011 · James A. Thomas, Caroline Pope, et al. · Hepatology · 351
Fontan-associated liver disease: A review
2019 · Timothy T. Gordon-Walker, Kevin Bove, et al. · Journal of Cardiology · 230
Hepatocellular Carcinoma After Fontan Operation
2018 · Alexander C. Egbe, Joseph T. Poterucha, et al. · Circulation · 128
Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo
2013 · Jonathan A. Fallowfield, Annette L. Hayden, et al. · Hepatology · 96
Hepatocellular carcinoma and the Fontan circulation: Clinical presentation and outcomes
2020 · Mathias Possner, Timothy Gordon-Walker, et al. · International Journal of Cardiology · 78
Exercise-Induced Systemic Venous Hypertension in the Fontan Circulation
2016 · Devaraj Navaratnam, Samantha Fitzsimmons, et al. · The American Journal of Cardiology · 60
Characterization of Two Novel Homozygous Missense Mutations Involving Codon 6 and 259 of Type II 3 -Hydroxysteroid Dehydrogenase (3 HSD) Gene Causing, Respectively, Nonsalt-Wasting and Salt-Wasting 3 HSD Deficiency Disorder
2000 · Li Zhang, J. Ian Mason, et al. · The Journal of Clinical Endocrinology & Metabolism · 32
Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools
2023 · Jennifer A. Scott, Andrew M. Jones, et al. · Heliyon · 10
OC-157 Physiological changes in matrix stiffness modulate hepatic progenitor cell morphology, proliferation and differentiation
2012 · T T Gordon-Walker, J Schrader, et al. · Gut · 4
PDF
The Edinburgh Gastric Ulcer Score (EGUS): evaluation of a risk tool for gastric ulcer follow-up
2024 · Rebecca K Grant, William M Brindle, et al. · Frontline Gastroenterology · 2
P065 Genetic evaluation of patients listed for liver transplantation with cryptogenic cirrhosis
2021 · Jeremy Nayagam, Rhiannon Taylor, et al. · Gut · 2
PDF
Editorial: alleviating the itch—the safety of rifampicin in the real world
2018 · T. T. Gordon‐Walker · Alimentary Pharmacology & Therapeutics · 2
PDF
PWE-259 The efficacy of methotrexate in Crohn's disease: a clinical perspective
2012 · T T Gordon-Walker, M W Stahl, et al. · Gut · 2
PDF
1113 Uniaxial Strain Facilitates Cytoskeletal Realignment and Promotes a Fibrogenic Phenotype in Hepatic Stellate Cells in Vitro
2013 · T.T. Gordon-Walker, R.L. Aucott, et al. · Journal of Hepatology · 1
P38 Matrix stiffness regulates proliferation, differentiation and chemotherapeutic responsiveness in hepatocellular carcinoma
2010 · T Gordon-Walker, J Schrader, et al. · Gut · 1
P19 Patient assessment and characteristics in a single-centre Fontan-associated liver disease cohort
2020 · Bruce Dickson, Alexandra Thompson, et al. · Gut
PDF
Effect of matrix stiffness on the behaviour of liver resident cell populations in chronic liver disease and hepatocarcinogenesis
2014 · Timothy T. Gordon‐Walker, Timothy Thomas Gordon Walker · ERA
PMO-129 Relaxin reduces portal hypertension through stimulation of hepatic nitric oxide production
2012 · J Fallowfield, V Snowdon, et al. · Gut
PDF
404 Culturing Alternatively Activated Macrophages Onto Type Iii Collagen Causes the Development of an Intermediate Classic/alternative Phenotype
2012 · M. van Deemter, P. Ramachandran, et al. · Journal of Hepatology
Targeting the cytoskeleton inhibits proliferation of hepatoma cells by suppressing mitogenic signalling
2012 · J Schrader, TT Gordon-Walker, et al. · Zeitschrift für Gastroenterologie
Abnormal Liver Function Tests: Diagnostic Approach
2011 · Timothy T. Gordon‐Walker, John P. Iredale · Wiley eBooks
Macrophage Cell Therapy Causes the Hepatic Recruitment of Host Effector Cells and Improves Structure and Function in a Murine Model of Chronic Liver Disease
2010 · James A. Thomas, Davina Wojtacha, et al. · Hepatology
Relaxin Inhibits Hepatic Myofibroblast Contractility and Modulates Portal Hypertension in Vivo
2010 · Jonathan A. Fallowfield, Annette Hayden, et al. · Hepatology
Works count: 30
Citation count: 2,787
H-index: 10
I10-index: 10
Year
Topic
Type